A 9 month 100% position as a researcher is vacant. Drug development, B cell malignancy, Department of Immunology, Oslo University Hospital.

The researcher will work on an ongoing project investigating the efficacy of a drug candidate targeting a B cell malignancy. The project will be led by prof. Ludvig A. Munthe at the Department of Immunology, Oslo University Hospital and RCN CoE PRIMA, University of Oslo. The project is funded by the RCN and a Biotech company in collaboration with the Munthe group. The research group is part of a stimulating and international research environment of about 100 scientists working on various aspects of immunology. Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and we encourage all qualified candidates, regardless of background, to apply!

Duties and responsibilitie...